Xu, Yifan
Zhang, Wenri H.
Allen, Elyse M.
Fedorov, Lev M.
Barnes, Anthony P.
Qian, Zu Yuan
Bah, Thierno Madjou
Li, Yuandong
Wang, Ruikang K.
Shangraw, Robert E.
Alkayed, Nabil J.
Funding for this research was provided by:
Foundation of Anesthesia Education and Research (RFG-08-15-2019)
National Institutes of Health (NS108501)
Article History
Received: 8 July 2022
Revised: 2 September 2022
Accepted: 26 September 2022
First Online: 1 October 2022
Declarations
:
: Dr. Alkayed is co-inventor of technologies related to GPR39 that have been licensed to private companies. This potential conflict of interest has been reviewed and managed by Oregon Health and Science University.
: Not applicable. No human subjects were involved.
: No studies were performed on human subjects. Studies on animals were conducted in accordance with National Institute of Health guidelines for use of animals in research, and protocols were approved by the Animal Care and Use Committee at Oregon Health & Science University.
: All authors have reviewed the final manuscript, agreed with the content, and gave explicit consent to publish it.
: Dr. Alkayed is co-inventor of technology related to GPR39 that has been licensed to VasoCardea. This potential conflict of interest has been reviewed and managed by Oregon Health and Science University. All other authors have nothing to disclose.